| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comprehensive in silico analysis of multiple sclerosis related non-synonymous SNPs and their potential effects on protein structure and function
|
Erkal, Burçin
|
|
|
68 |
C |
p.
|
artikel
|
| 2 |
Acute myocardial infarction in patients with multiple sclerosis; An insight from 1785 cases in the United States
|
Ramphul, Kamleshun
|
|
|
68 |
C |
p.
|
artikel
|
| 3 |
Altered functional connectivity associated with cognitive impairment in neuromyelitis optica spectrum disorder
|
Yang, Yang
|
|
|
68 |
C |
p.
|
artikel
|
| 4 |
Amyloid-Eszett (Aß), a false positive of amyloid-beta (Aβ)
|
Teixeira da Silva, Jaime A.
|
|
|
68 |
C |
p.
|
artikel
|
| 5 |
A pilot study comparing myelin measurements from myelin water imaging and 11C-PIB PET in multiple sclerosis
|
Vavasour, Irene M
|
|
|
68 |
C |
p.
|
artikel
|
| 6 |
AQP4-IgG-positive neuromyelitis optica spectrum disorder and temporally detected neoplasms: case report and systematic review
|
Apiraksattayakul, Natnasak
|
|
|
68 |
C |
p.
|
artikel
|
| 7 |
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study
|
Miele, Giuseppina
|
|
|
68 |
C |
p.
|
artikel
|
| 8 |
Asymptomatic MRI lesions in pediatric-onset AQP4-IgG positive NMOSD
|
Paolilo, Renata Barbosa
|
|
|
68 |
C |
p.
|
artikel
|
| 9 |
A systematic review with meta-analysis on balance, fatigue, and motor function following aquatic therapy in patients with multiple sclerosis
|
Shariat, Ardalan
|
|
|
68 |
C |
p.
|
artikel
|
| 10 |
Benefits of early treatment with natalizumab: a real-world study
|
Ontaneda, Daniel
|
|
|
68 |
C |
p.
|
artikel
|
| 11 |
Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis
|
Zjukovskaja, Christina
|
|
|
68 |
C |
p.
|
artikel
|
| 12 |
B-lymphocyte-guided retreatment contributes to establish good effectiveness and safety profile in MS patients treated with rituximab
|
Chico-García, Juan Luis
|
|
|
68 |
C |
p.
|
artikel
|
| 13 |
Brain volumetric correlates of remotely versus in-person administered symbol digit modalities test in multiple sclerosis
|
Buyukturkoglu, Korhan
|
|
|
68 |
C |
p.
|
artikel
|
| 14 |
Can fatigue predict the worsening of multiple sclerosis one year later? An explorative study with participants referred to assess their ability to work
|
Valadkevičienė, Daiva
|
|
|
68 |
C |
p.
|
artikel
|
| 15 |
Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies
|
Al-Chalabi, Mustafa
|
|
|
68 |
C |
p.
|
artikel
|
| 16 |
Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre- and post-SARS-CoV-2 vaccination periods: Insights from Israel
|
Weberpals, Janick
|
|
|
68 |
C |
p.
|
artikel
|
| 17 |
Cognition and proprioception in persons with multiple sclerosis and healthy controls: Nascent findings
|
Henning, David A.
|
|
|
68 |
C |
p.
|
artikel
|
| 18 |
Core stability-based balance training and kinesio taping for balance, trunk control, fear of falling and walking capacity in patients with multiple sclerosis: A randomized single-blinded study
|
Yaşa, Mustafa Ertuğrul
|
|
|
68 |
C |
p.
|
artikel
|
| 19 |
COVID-19 severity among patients with multiple sclerosis treated with cladribine: A systematic review and meta-analysis
|
Albanese, Angela
|
|
|
68 |
C |
p.
|
artikel
|
| 20 |
CSF β-amyloid is not a prognostic marker in multiple sclerosis patients
|
Petitfour, Justine
|
|
|
68 |
C |
p.
|
artikel
|
| 21 |
Cut-off evaluation of intrathecal oligoclonal bands of IgM in relapsing-remitting multiple sclerosis; a retrospective study
|
Hvaring, Charlotte
|
|
|
68 |
C |
p.
|
artikel
|
| 22 |
Cytokines/chemokines and soluble immune checkpoint molecules in anti-GABAB receptor encephalitis
|
Qiao, Shan
|
|
|
68 |
C |
p.
|
artikel
|
| 23 |
Defining the experiences of adolescent patients with multiple sclerosis in transition from pediatric care to adult care
|
Yüksel Yılmaz, Didem
|
|
|
68 |
C |
p.
|
artikel
|
| 24 |
Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis
|
Saposnik, Gustavo
|
|
|
68 |
C |
p.
|
artikel
|
| 25 |
Details and outcomes of a large cohort of MOG-IgG associated optic neuritis
|
Chen, John J.
|
|
|
68 |
C |
p.
|
artikel
|
| 26 |
Diagnosis concealment is prevalent in MS, and associated with diagnosis experience
|
Leavitt, V.M.
|
|
|
68 |
C |
p.
|
artikel
|
| 27 |
Different doses of Rituximab for the therapy of Neuromyelitis optica spectrum disorder: A systematic review and meta-analysis
|
Wei, Kenhui
|
|
|
68 |
C |
p.
|
artikel
|
| 28 |
Discussing the potential for progression with patients newly diagnosed with multiple sclerosis: When, how, and why?
|
Shosha, Eslam
|
|
|
68 |
C |
p.
|
artikel
|
| 29 |
Disease modifying therapies and disease activity during pregnancy and postpartum in a contemporary cohort of relapsing Multiple Sclerosis patients
|
Lescot, Lucile
|
|
|
68 |
C |
p.
|
artikel
|
| 30 |
Do people with multiple sclerosis perceive upper limb improvements from robotic-mediated therapy? A mixed methods study
|
Tedesco Triccas, L.
|
|
|
68 |
C |
p.
|
artikel
|
| 31 |
Dramatic changes in multiple sclerosis incidence in Iran may be related to the “Will Rogers phenomenon”
|
Hosseinzadeh, Ali
|
|
|
68 |
C |
p.
|
artikel
|
| 32 |
Effectiveness of first generation disease-modifying therapy to prevent conversion to secondary progressive multiple sclerosis
|
Tedeholm, H
|
|
|
68 |
C |
p.
|
artikel
|
| 33 |
Effect of eight weeks respiratory muscle training on respiratory capacity, functional capacity and quality of life on subjects with mild to moderate relapsing-remitting multiple sclerosis: A single-blinded randomized controlled trial
|
Ghannadi, Shima
|
|
|
68 |
C |
p.
|
artikel
|
| 34 |
Effect of teriflunomide on Epstein–Barr virus shedding in relapsing-remitting multiple sclerosis patients: Outcomes from a real-world pilot cohort study
|
Gold, Julian
|
|
|
68 |
C |
p.
|
artikel
|
| 35 |
Effects of hippotherapy simulation exercise vs. conventional home exercises on muscle strength and balance in people with multiple sclerosis: A randomized controlled trial
|
Salbaş, Ender
|
|
|
68 |
C |
p.
|
artikel
|
| 36 |
Effects of SativexⓇ on cognitive function in patients with multiple sclerosis: A systematic review and meta-analysis
|
Dykukha, Igor
|
|
|
68 |
C |
p.
|
artikel
|
| 37 |
Efficacy, safety and patient reported outcomes in patients with active relapsing multiple sclerosis treated with ocrelizumab: Final results from the PRO-MSACTIVE study
|
Manchon, Eric
|
|
|
68 |
C |
p.
|
artikel
|
| 38 |
Emerging trends in multiple sclerosis research
|
Dalla Costa, Gloria
|
|
|
68 |
C |
p.
|
artikel
|
| 39 |
Epidemiologic trends of multiple sclerosis in Puerto Rico (2013–2020)
|
Chinea, Angel
|
|
|
68 |
C |
p.
|
artikel
|
| 40 |
Epidemiology of familial multiple sclerosis and its comparison to sporadic form in Markazi Province, Iran
|
Faraji, Fardin
|
|
|
68 |
C |
p.
|
artikel
|
| 41 |
Epstein–Barr virus antibody in newly diagnosed multiple sclerosis patients and its association with relapse severity and lesion location
|
Olmez, Onder
|
|
|
68 |
C |
p.
|
artikel
|
| 42 |
Evaluating the energy regulatory hormones of nesfatin-1, irisin, adropin and preptin in multiple sclerosis
|
Algul, Sermin
|
|
|
68 |
C |
p.
|
artikel
|
| 43 |
Evidence for novel cell defense mechanisms sustained by dimethyl fumarate in multiple sclerosis patients: the HuR/SOD2 cascade
|
Mallucci, Giulia
|
|
|
68 |
C |
p.
|
artikel
|
| 44 |
Evidence of increased sequestration of pro-resolving lipid mediators within brain esterified lipid pools of multiple sclerosis patients
|
Shen, Qing
|
|
|
68 |
C |
p.
|
artikel
|
| 45 |
Exploring the impact of the COVID-19 pandemic on social isolation and mental health in people with MS
|
Ling, Shu
|
|
|
68 |
C |
p.
|
artikel
|
| 46 |
Factors correlated with neuropathic pain in patients with neuromyelitis optica spectrum disorder
|
Zhang, Xue
|
|
|
68 |
C |
p.
|
artikel
|
| 47 |
Fatal neuromyelitis optica after COVID-19 vaccination
|
Boldrini, Vinícius de Oliveira
|
|
|
68 |
C |
p.
|
artikel
|
| 48 |
Fragmentation, circadian amplitude, and fractal pattern of daily-living physical activity in people with multiple sclerosis: Is there relevant information beyond the total amount of physical activity?
|
Salomon, Amit
|
|
|
68 |
C |
p.
|
artikel
|
| 49 |
Frequency of myelin oligodendrocyte glycoprotein antibodies in pediatric onset multiple sclerosis
|
Solmaz, Ismail
|
|
|
68 |
C |
p.
|
artikel
|
| 50 |
High-intensity resistance training in people with multiple sclerosis experiencing fatigue: A randomised controlled trial
|
Englund, S.
|
|
|
68 |
C |
p.
|
artikel
|
| 51 |
High persistence and low adverse events burden in cladribine treated MS patients from Argentina
|
Negrotto, L.
|
|
|
68 |
C |
p.
|
artikel
|
| 52 |
Humoral efficacy of the third SARS-CoV-2 vaccine dose in Multiple Sclerosis subjects undergoing different disease-modifying therapies
|
Maniscalco, Giorgia Teresa
|
|
|
68 |
C |
p.
|
artikel
|
| 53 |
Hypogammaglobulinemia: A contributing factor to multiple sclerosis fatigue?
|
Diem, L.
|
|
|
68 |
C |
p.
|
artikel
|
| 54 |
Identification of cognitive impairment, depression, and fatigue among multiple sclerosis patients in a large comprehensive care center: A mixed-methods, qualitative study
|
Tornatore, Carlo
|
|
|
68 |
C |
p.
|
artikel
|
| 55 |
Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemic
|
Jakimovski, Dejan
|
|
|
68 |
C |
p.
|
artikel
|
| 56 |
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM
|
Rojas, Juan I.
|
|
|
68 |
C |
p.
|
artikel
|
| 57 |
Individual differences in visual evoked potential latency are associated with variance in brain tissue volume in people with multiple sclerosis: An analysis of brain function-structure correlates
|
Covey, Thomas J
|
|
|
68 |
C |
p.
|
artikel
|
| 58 |
Infection risk in a real-world cohort of patients treated with long-term B-cell depletion for autoimmune neurologic disease
|
Peters, John
|
|
|
68 |
C |
p.
|
artikel
|
| 59 |
Intravenous ofatumumab treatment of multiple sclerosis and related disorders: An observational study
|
El Mahdaoui, Sahla
|
|
|
68 |
C |
p.
|
artikel
|
| 60 |
Ischemic stroke in neurosarcoidosis: A retrospective cohort analysis
|
Hutto, Spencer K.
|
|
|
68 |
C |
p.
|
artikel
|
| 61 |
JCV seroconversion rate during the SARS COVID-19 pandemic
|
Vigiser, I.
|
|
|
68 |
C |
p.
|
artikel
|
| 62 |
Lessons learned from clinical trials of exercise and physical activity in people with MS – guidance for improving the quality of future research
|
Motl, Robert W.
|
|
|
68 |
C |
p.
|
artikel
|
| 63 |
Life expectancy in multiple sclerosis by EDSS score
|
Walz, Lucas
|
|
|
68 |
C |
p.
|
artikel
|
| 64 |
Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy
|
Bazzi, Sam A.
|
|
|
68 |
C |
p.
|
artikel
|
| 65 |
Longitudinal stability of JCV antibody index in Natalizumab treated people with multiple sclerosis
|
Gaughan, M.
|
|
|
68 |
C |
p.
|
artikel
|
| 66 |
Medication habits among persons with multiple sclerosis
|
Neter, Efrat
|
|
|
68 |
C |
p.
|
artikel
|
| 67 |
Modulation of salivary ICAM-1 and SIRT1 by disease modifying drugs in undepressed relapsing-remitting multiple sclerosis patients
|
Gammoh, Omar
|
|
|
68 |
C |
p.
|
artikel
|
| 68 |
MOG antibody prevalence in adult optic neuritis and clinical predictive factors for diagnosis: A Chinese cohort study
|
Song, Honglu
|
|
|
68 |
C |
p.
|
artikel
|
| 69 |
Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies
|
Beesley, R.
|
|
|
68 |
C |
p.
|
artikel
|
| 70 |
Multiple sclerosis and migraine: Links, management and implications
|
Mrabet, Saloua
|
|
|
68 |
C |
p.
|
artikel
|
| 71 |
Mycophenolate mofetil: An alternative disease-modifying agent for MOG-IgG-associated disorders in childhood: A single-center bidirectional cohort study
|
Zhou, Ji
|
|
|
68 |
C |
p.
|
artikel
|
| 72 |
Myelin oligodendrocyte glycoprotein antibody-associated aseptic meningitis without neurological parenchymal lesions: A novel phenotype
|
Lin, Sufang
|
|
|
68 |
C |
p.
|
artikel
|
| 73 |
Neutropenia complicating anti-CD20 treatment in patients with multiple sclerosis: A retrospective case series and a systematic review of reported cases
|
Rossi, Lucrezia
|
|
|
68 |
C |
p.
|
artikel
|
| 74 |
New, diagnostic flicker test for optic neuritis shows specific stages following disease onset
|
Pihl-Jensen, Gorm
|
|
|
68 |
C |
p.
|
artikel
|
| 75 |
No association between body composition and walking outcomes in multiple sclerosis
|
Jeng, Brenda
|
|
|
68 |
C |
p.
|
artikel
|
| 76 |
Objective and subjective measures of daily physical activity in persons with Multiple Sclerosis beginning a rehabilitation regime: A cross-sectional study
|
Torchio, Alessandro
|
|
|
68 |
C |
p.
|
artikel
|
| 77 |
OCT and VEP correlate to disability in secondary progressive multiple sclerosis
|
Eklund, Anna
|
|
|
68 |
C |
p.
|
artikel
|
| 78 |
Oligoclonal IgM bands are a promising biomarker for long-term cognitive outcomes in multiple sclerosis
|
Coll-Martinez, Clàudia
|
|
|
68 |
C |
p.
|
artikel
|
| 79 |
Oligoclonal M bands unveil occult inflammation in multiple sclerosis
|
Casanova, Bonaventura
|
|
|
68 |
C |
p.
|
artikel
|
| 80 |
Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinations
|
Kim, Ki Hoon
|
|
|
68 |
C |
p.
|
artikel
|
| 81 |
Oral disease modifying therapies – A game changer for treatment decision in untreated patients with RRMS and CIS? – A swiss single center cross-sectional study
|
Finkener, Sebastian
|
|
|
68 |
C |
p.
|
artikel
|
| 82 |
Pain in neuromyelitis optic spectrum disorder
|
Xue, Huiru
|
|
|
68 |
C |
p.
|
artikel
|
| 83 |
Participant characteristics of existing exercise studies in persons with multiple sclerosis – A systematic review identifying literature gaps
|
Gaemelke, Tobias
|
|
|
68 |
C |
p.
|
artikel
|
| 84 |
Peripheral neuropathy and MOG-IgG: A clinical and neuropathological retrospective study
|
Dinoto, Alessandro
|
|
|
68 |
C |
p.
|
artikel
|
| 85 |
Posterior tibial nerve stimulation as a neuromodulation therapy in treatment of neurogenic overactive bladder in multiple sclerosis: A prospective randomized controlled study
|
Marzouk, Mohamed H.
|
|
|
68 |
C |
p.
|
artikel
|
| 86 |
Post marketing new adverse effects of oral therapies in multiple sclerosis: A systematic review
|
Sahraian, Mohammad Ali
|
|
|
68 |
C |
p.
|
artikel
|
| 87 |
Potentially preventable hospitalizations and use of preventive services among people with multiple sclerosis: Large cohort study, USA
|
Khan, Anam
|
|
|
68 |
C |
p.
|
artikel
|
| 88 |
Predicting falls in adults with multiple sclerosis using patient-reported measures: Are perceptions of dual-tasking missing?
|
VanNostrand, Michael
|
|
|
68 |
C |
p.
|
artikel
|
| 89 |
Prevalence of multiple sclerosis in Guangzhou, China: A population-based case-finding prospective study
|
Liu, Zifeng
|
|
|
68 |
C |
p.
|
artikel
|
| 90 |
Quantifying lower extremity inter-segmental coordination variability during walking in people with multiple sclerosis with high and low fear of falling
|
Mofateh, Razieh
|
|
|
68 |
C |
p.
|
artikel
|
| 91 |
Quantitative and qualitative features of acute phase-adverse events following SARS-CoV-2 vaccination in a large sample of people with multiple sclerosis
|
Tavazzi, E.
|
|
|
68 |
C |
p.
|
artikel
|
| 92 |
Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis
|
Kong, Lingyao
|
|
|
68 |
C |
p.
|
artikel
|
| 93 |
Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis
|
Talbot, Jacob
|
|
|
68 |
C |
p.
|
artikel
|
| 94 |
Repeated forms, testing intervals, and SDMT performance in a large multiple sclerosis dataset
|
Fuchs, Tom A
|
|
|
68 |
C |
p.
|
artikel
|
| 95 |
Response: Treatment of multiple sclerosis as a single disease based on the body-pathology-environment model
|
Giovannoni, Gavin
|
|
|
68 |
C |
p.
|
artikel
|
| 96 |
Risk factors associated with permanent disability in neuromyelitis optica spectrum disorders
|
Valdivia-Tangarife, Edgar R.
|
|
|
68 |
C |
p.
|
artikel
|
| 97 |
Self-assessment of people with relapsing-remitting and progressive multiple sclerosis towards burden of disease, progression, and treatment utilization—Results of a large-scale cross-sectional online survey (MS Perspectives)
|
Bayas, A
|
|
|
68 |
C |
p.
|
artikel
|
| 98 |
Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study
|
Knapp, Rachel
|
|
|
68 |
C |
p.
|
artikel
|
| 99 |
Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios
|
Oezguen, Numan
|
|
|
68 |
C |
p.
|
artikel
|
| 100 |
Symbol digit modalities test predicts decline of off-road driving ability in Japanese patients with multiple sclerosis
|
Maeta, Manami
|
|
|
68 |
C |
p.
|
artikel
|
| 101 |
Symptom burden, management and treatment goals of people with MS spasticity: Results from SEEN-MSS, a large-scale, self-reported survey
|
Newsome, SD
|
|
|
68 |
C |
p.
|
artikel
|
| 102 |
The age at onset of relapsing-remitting multiple sclerosis has increased over the last five decades
|
Romero-Pinel, Lucía
|
|
|
68 |
C |
p.
|
artikel
|
| 103 |
The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome
|
Longbrake, Erin E.
|
|
|
68 |
C |
p.
|
artikel
|
| 104 |
The effectiveness of anodal tDCS and cognitive training on cognitive functions in multiple sclerosis; a randomized, double-blind, parallel-group study
|
Simani, Leila
|
|
|
68 |
C |
p.
|
artikel
|
| 105 |
The effect of therapeutic exercise on depressive symptoms in people with multiple sclerosis – A systematic review
|
Kyriakatis, Georgios Marios
|
|
|
68 |
C |
p.
|
artikel
|
| 106 |
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study
|
Ponzano, Marta
|
|
|
68 |
C |
p.
|
artikel
|
| 107 |
Theranostic potential of graphene quantum dots for multiple sclerosis
|
Demirdöğen, Birsen Can
|
|
|
68 |
C |
p.
|
artikel
|
| 108 |
The relationship between alexithymia, reading the mind in the eyes and cognition in patients with multiple sclerosis
|
Karpuz Seren, Burcu
|
|
|
68 |
C |
p.
|
artikel
|
| 109 |
The role of basal ganglia network in neural plasticity in neuromyelitis optica spectrum disorder with myelitis
|
Yang, Lili
|
|
|
68 |
C |
p.
|
artikel
|
| 110 |
The symbol digit modalities test and the paced auditory serial addition test involve more than processing speed
|
Berrigan, Lindsay I.
|
|
|
68 |
C |
p.
|
artikel
|
| 111 |
Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies
|
Baba, Cavid
|
|
|
68 |
C |
p.
|
artikel
|
| 112 |
Training-dependent plasticity and far transfer effect enhanced by Bobath rehabilitation in Multiple Sclerosis
|
Castelli, Letizia
|
|
|
68 |
C |
p.
|
artikel
|
| 113 |
Treatment of Multiple Sclerosis as a single disease based on the body-pathology-environment model
|
Naser Moghadasi, Abdorreza
|
|
|
68 |
C |
p.
|
artikel
|
| 114 |
Trends in the environmental risks associated with earlier onset in multiple sclerosis
|
Huang, Jesse
|
|
|
68 |
C |
p.
|
artikel
|
| 115 |
Updates on efficacy and safety outcomes of new and emerging disease modifying therapies and stem cell therapy for Multiple Sclerosis: A review
|
Peterson, Sarah
|
|
|
68 |
C |
p.
|
artikel
|
| 116 |
Use of retinal optical coherence tomography to differentiate suspected neuromyelitis optica spectrum disorder from multiple sclerosis: A cross-sectional study
|
Ayoubi, Nabil K. El
|
|
|
68 |
C |
p.
|
artikel
|
| 117 |
Visit-to-visit systolic blood pressure variability is associated with increased fatigue symptoms in multiple sclerosis patients
|
Goldman, Myla D.
|
|
|
68 |
C |
p.
|
artikel
|
| 118 |
What are T-cells telling us about how EBV causes MS?
|
Giovannoni, Gavin
|
|
|
68 |
C |
p.
|
artikel
|
| 119 |
What are the trends in the treatment of multiple sclerosis in recent studies? – A bibliometric analysis with global productivity during 1980–2021
|
Aykaç, Serdar
|
|
|
68 |
C |
p.
|
artikel
|
Tijdschrift beschrijving